Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Radiofrequency Ablation (RFA)
Treatment for Liver cancer due to hepatitis B
Typical Dosage: procedure-based
Effectiveness
90%
Safety Score
40%
Clinical Trials
70
Participants
8K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Dosage Range
procedure-based
Time to Effect
immediate (tumor destruction)
Treatment Duration
single session, repeat if recurrence
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$7,000
Side Effect Mgmt:$1,000
Total Annual:$8,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$40,000/QALY
QALYs Gained
4.5
Outcome-Based Costs
Cost per Responder
$35,556
Cost per Remission
$35,556
Comparison vs Surgical Resection
Cost Difference
$-30,000/year
Less expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Radiofrequency Ablation (RFA) Outcomes
for Liver cancer due to hepatitis B
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+90%
Common Side Effects
Pain (local)
+50%
Fever
+20%
Local bleeding/hematoma
+5%
Infection
+1%
Visceral injury
+1%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov